Lisper Wangeci Njeri1, William Otieno Ogallo2, David Gitonga Nyamu3, Sylvia Adisa Opanga3, Alfred Rugendo Birichi4. 1. Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, P.O. Box 46996-00100, Nairobi, Kenya. lisper2251@students.uonbi.ac.ke. 2. Biomedical Informatics, Columbia University, New York, USA. 3. Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya. 4. Department of Pharmacy, Kenyatta National Hospital, P.O. Box 334-00618, Nairobi, Kenya.
Abstract
BACKGROUND: Chronic kidney disease (CKD) patients are prone to medication-related problems (MRPs). Few studies address the clinical relevance of MRPs among CKD patients in sub-Saharan Africa. OBJECTIVE: To investigate the frequency and predictors of MRPs among adult CKD patients treated at a tertiary care facility in an urban sub-Saharan setting. SETTING: Kenyatta National Hospital in Nairobi, Kenya. METHOD: A cross-sectional study involving 60 adult patients with CKD was carried out. Data were collected through structured interviews and patient chart reviews between April 2016 and June 2016. MRPs identified from the collected data were classified according to Hepler and Strand classification. The frequencies of the identified MRPs were computed and logistic regression used to investigate the associations between the MRPs and covariates in the data. MAIN OUTCOME MEASURES: frequencies and predictors of MRPs. RESULTS: 271 MRPs were identified. The commonest MRPs were drug interactions (21.8%), indication without drug (18.1%) and medication non-adherence (15.5%). Compared to patients with CKD stage 3, patients with CKD stage 4 were 5.9 times more likely to have an improper drug selection and 4.7 times more likely to experience overdosage. Other significant predictors of MRPs were the number of medications per prescription and the number of comorbidities per patient. CONCLUSION: This study found a high frequency of MRPs among patients with chronic kidney disease receiving care in urban sub-Saharan tertiary hospital settings. The predictors of MRPs among CKD patients in this setting are likely to be multifactorial and include the CKD stage, polypharmacy, and comorbidities.
BACKGROUND:Chronic kidney disease (CKD) patients are prone to medication-related problems (MRPs). Few studies address the clinical relevance of MRPs among CKDpatients in sub-Saharan Africa. OBJECTIVE: To investigate the frequency and predictors of MRPs among adult CKDpatients treated at a tertiary care facility in an urban sub-Saharan setting. SETTING: Kenyatta National Hospital in Nairobi, Kenya. METHOD: A cross-sectional study involving 60 adult patients with CKD was carried out. Data were collected through structured interviews and patient chart reviews between April 2016 and June 2016. MRPs identified from the collected data were classified according to Hepler and Strand classification. The frequencies of the identified MRPs were computed and logistic regression used to investigate the associations between the MRPs and covariates in the data. MAIN OUTCOME MEASURES: frequencies and predictors of MRPs. RESULTS: 271 MRPs were identified. The commonest MRPs were drug interactions (21.8%), indication without drug (18.1%) and medication non-adherence (15.5%). Compared to patients with CKD stage 3, patients with CKD stage 4 were 5.9 times more likely to have an improper drug selection and 4.7 times more likely to experience overdosage. Other significant predictors of MRPs were the number of medications per prescription and the number of comorbidities per patient. CONCLUSION: This study found a high frequency of MRPs among patients with chronic kidney disease receiving care in urban sub-Saharan tertiary hospital settings. The predictors of MRPs among CKDpatients in this setting are likely to be multifactorial and include the CKD stage, polypharmacy, and comorbidities.
Authors: Meera Viswanathan; Leila C Kahwati; Carol E Golin; Susan J Blalock; Emmanuel Coker-Schwimmer; Rachael Posey; Kathleen N Lohr Journal: JAMA Intern Med Date: 2015-01 Impact factor: 21.873
Authors: Chester H Fox; Andrew Swanson; Linda S Kahn; Katheryn Glaser; Brian M Murray Journal: J Am Board Fam Med Date: 2008 Nov-Dec Impact factor: 2.657
Authors: Ernest K Sumaili; Eric P Cohen; Chantal V Zinga; Jean-Marie Krzesinski; Nestor M Pakasa; Nazaire M Nseka Journal: BMC Nephrol Date: 2009-07-21 Impact factor: 2.388
Authors: Mylapuram Rama; Gayathri Viswanathan; Leelavathi D Acharya; R P Attur; P N Reddy; S V Raghavan Journal: Indian J Pharm Sci Date: 2012-01 Impact factor: 0.975
Authors: Julie A Wagner; Angela Bermudez-Millan; S Megan Berthold; Thomas Buckley; Orfeu M Buxton; Richard Feinn; Theanvy Kuoch; Sengly Kong; Mackenzie Lim; Christina Polomoff; Mary Scully Journal: Health Psychol Behav Med Date: 2022-01-24
Authors: Roland Nnaemeka Okoro; Ibrahim Ummate; John David Ohieku; Sani Ibn Yakubu; Maxwell Ogochukwu Adibe; Mathew Jegbefume Okonta Journal: Med Access Point Care Date: 2020-09-16